rs146578303

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_152783.5(D2HGDH):​c.1276G>A​(p.Ala426Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00716 in 1,603,256 control chromosomes in the GnomAD database, including 72 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0061 ( 6 hom., cov: 33)
Exomes 𝑓: 0.0073 ( 66 hom. )

Consequence

D2HGDH
NM_152783.5 missense

Scores

2
8
8

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:1B:10

Conservation

PhyloP100: 5.84

Publications

15 publications found
Variant links:
Genes affected
D2HGDH (HGNC:28358): (D-2-hydroxyglutarate dehydrogenase) This gene encodes D-2hydroxyglutarate dehydrogenase, a mitochondrial enzyme belonging to the FAD-binding oxidoreductase/transferase type 4 family. This enzyme, which is most active in liver and kidney but also active in heart and brain, converts D-2-hydroxyglutarate to 2-ketoglutarate. Mutations in this gene are present in D-2-hydroxyglutaric aciduria, a rare recessive neurometabolic disorder causing developmental delay, epilepsy, hypotonia, and dysmorphic features. [provided by RefSeq, Jul 2008]
D2HGDH Gene-Disease associations (from GenCC):
  • D-2-hydroxyglutaric aciduria 1
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • D-2-hydroxyglutaric aciduria
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010284096).
BP6
Variant 2-241755984-G-A is Benign according to our data. Variant chr2-241755984-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 158410.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00609 (927/152310) while in subpopulation NFE AF = 0.00664 (452/68026). AF 95% confidence interval is 0.00614. There are 6 homozygotes in GnomAd4. There are 556 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
D2HGDHNM_152783.5 linkc.1276G>A p.Ala426Thr missense_variant Exon 9 of 10 ENST00000321264.9 NP_689996.4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
D2HGDHENST00000321264.9 linkc.1276G>A p.Ala426Thr missense_variant Exon 9 of 10 1 NM_152783.5 ENSP00000315351.4

Frequencies

GnomAD3 genomes
AF:
0.00609
AC:
927
AN:
152192
Hom.:
6
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00138
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00268
Gnomad ASJ
AF:
0.00807
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00228
Gnomad FIN
AF:
0.0308
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00664
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.00710
AC:
1749
AN:
246360
AF XY:
0.00710
show subpopulations
Gnomad AFR exome
AF:
0.000873
Gnomad AMR exome
AF:
0.00221
Gnomad ASJ exome
AF:
0.00830
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.0281
Gnomad NFE exome
AF:
0.00780
Gnomad OTH exome
AF:
0.00828
GnomAD4 exome
AF:
0.00727
AC:
10545
AN:
1450946
Hom.:
66
Cov.:
36
AF XY:
0.00701
AC XY:
5048
AN XY:
719654
show subpopulations
African (AFR)
AF:
0.000873
AC:
29
AN:
33236
American (AMR)
AF:
0.00200
AC:
89
AN:
44416
Ashkenazi Jewish (ASJ)
AF:
0.00828
AC:
215
AN:
25968
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39350
South Asian (SAS)
AF:
0.00226
AC:
194
AN:
85996
European-Finnish (FIN)
AF:
0.0264
AC:
1376
AN:
52150
Middle Eastern (MID)
AF:
0.000870
AC:
5
AN:
5744
European-Non Finnish (NFE)
AF:
0.00742
AC:
8193
AN:
1104292
Other (OTH)
AF:
0.00743
AC:
444
AN:
59794
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
652
1304
1956
2608
3260
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
320
640
960
1280
1600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00609
AC:
927
AN:
152310
Hom.:
6
Cov.:
33
AF XY:
0.00747
AC XY:
556
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.00137
AC:
57
AN:
41574
American (AMR)
AF:
0.00268
AC:
41
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00807
AC:
28
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00228
AC:
11
AN:
4824
European-Finnish (FIN)
AF:
0.0308
AC:
327
AN:
10616
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00664
AC:
452
AN:
68026
Other (OTH)
AF:
0.00473
AC:
10
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
49
98
147
196
245
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00531
Hom.:
1
Bravo
AF:
0.00387
TwinsUK
AF:
0.00485
AC:
18
ALSPAC
AF:
0.00778
AC:
30
ESP6500AA
AF:
0.00159
AC:
7
ESP6500EA
AF:
0.00757
AC:
65
ExAC
AF:
0.00707
AC:
858
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.00638
EpiControl
AF:
0.00712

ClinVar

Significance: Benign/Likely benign
Submissions summary: Uncertain:1Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:4
Feb 23, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 07, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

D2HGDH: BS2 -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

D-2-hydroxyglutaric aciduria 1 Benign:3
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

not specified Benign:2
Apr 28, 2015
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 17, 2017
Institute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's Hospital
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BS1, BP6; This alteration has an allele frequency that is greater than expected for the associated disease, and was reported as a benign/likely benign alteration by a reputable source (ClinVar or other correspondence from a clinical testing laboratory). -

D2HGDH-related disorder Benign:1
Apr 15, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.0020
T
BayesDel_noAF
Pathogenic
0.23
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.29
T;.
Eigen
Uncertain
0.28
Eigen_PC
Uncertain
0.30
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.86
D;T
MetaRNN
Benign
0.010
T;T
MetaSVM
Benign
-0.52
T
MutationAssessor
Uncertain
2.2
M;.
PhyloP100
5.8
PrimateAI
Uncertain
0.59
T
PROVEAN
Uncertain
-2.4
N;D
REVEL
Uncertain
0.61
Sift
Benign
0.17
T;T
Sift4G
Benign
0.17
T;T
Polyphen
0.41
B;.
Vest4
0.82
MVP
0.89
MPC
0.39
ClinPred
0.025
T
GERP RS
5.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.32
gMVP
0.87
Mutation Taster
=40/60
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146578303; hg19: chr2-242695399; COSMIC: COSV100344692; COSMIC: COSV100344692; API